These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36274093)

  • 41. Gene Expression Profiling of Mediastinal Gray Zone Lymphoma and Its Relationship to Primary Mediastinal B-cell Lymphoma and Classical Hodgkin Lymphoma.
    Pittaluga S; Nicolae A; Wright GW; Melani C; Roschewski M; Steinberg S; Huang D; Staudt LM; Jaffe ES; Wilson WH
    Blood Cancer Discov; 2020 Sep; 1(2):155-161. PubMed ID: 32914098
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dendritic Cell Markers and PD-L1 are Expressed in Mediastinal Gray Zone Lymphoma.
    Pelland K; Mathews S; Kamath A; Cohen P; Hudnall SD; Cotta CV; Xu ML
    Appl Immunohistochem Mol Morphol; 2018; 26(10):e101-e106. PubMed ID: 29189264
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The utility of IMP3 immunohistochemical staining in differentiating nodular lymphocyte predominant Hodgkin Lymphoma from T-Cell/Histiocyte-Rich large B-Cell lymphoma.
    Kosari F; Bakhshi T; Ameli F; Mokhtari M
    BMC Cancer; 2022 Dec; 22(1):1359. PubMed ID: 36577979
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeted Mutational Profiling Reveals Clonal Relationships in Metachronous Occurrence of Classic Hodgkin and Mediastinal Large B-Cell Lymphomas.
    Singh K; Lezama LS; Kurzer J; Oak J; Schultz LM; Walkush A; Cheng TC; Chen EH; May WA; Chang C; Link MP; Advani RH; Suarez CJ; Natkunam Y
    Am J Surg Pathol; 2023 Jan; 47(1):81-90. PubMed ID: 36001451
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microenvironmental immune cell alterations across the spectrum of nodular lymphocyte predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma.
    Panayi C; Akarca AU; Ramsay AD; Shankar AG; Falini B; Piris MA; Linch D; Marafioti T
    Front Oncol; 2023; 13():1267604. PubMed ID: 37854674
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Flow Cytometric Detection of the Double-Positive (CD4+CD8+)/PD-1bright T-Cell Subset Is Useful in Diagnosing Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
    Chen ZW; Wizniak J; Shang C; Lai R
    Arch Pathol Lab Med; 2022 Jun; 146(6):718-726. PubMed ID: 34506624
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Difficult Diagnosis between B Cell Lymphoma and Classical Hodgkin's Lymphoma.
    Rentas Torres Y; Rodríguez-López JL; Valentin M; Silva H
    Bol Asoc Med P R; 2015; 107(3):98-101. PubMed ID: 26742206
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anaplastic variant of diffuse large B-cell lymphoma: Reappraisal as a nodal disease with sinusoidal involvement.
    Megahed NA; Kohno K; Sakakibara A; Eladl AE; Elsayed AA; Wu CC; Suzuki Y; Takahara T; Kato S; Nakamura S; Satou A; Asano N
    Pathol Int; 2019 Dec; 69(12):697-705. PubMed ID: 31872533
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primary Mediastinal Nodal and Extranodal Non-Hodgkin Lymphomas: Current Concepts, Historical Evolution, and Useful Diagnostic Approach: Part 2.
    Piña-Oviedo S; Moran CA
    Adv Anat Pathol; 2019 Nov; 26(6):371-389. PubMed ID: 31567129
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Geographic Variability of Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
    Xia D; Sayed S; Moloo Z; Gakinya SM; Mutuiri A; Wawire J; Okiro P; Courville EL; Hasserjian RP; Sohani AR
    Am J Clin Pathol; 2022 Feb; 157(2):231-243. PubMed ID: 34542569
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Grey Zones of Classic Hodgkin Lymphoma.
    Bosch-Schips J; Granai M; Quintanilla-Martinez L; Fend F
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35159009
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Complexities in the diagnosis of large B-cell lymphomas, classic Hodgkin lymphomas and overlapping peripheral T-cell lymphomas simplified: An evidence-based guide.
    Wen KW; Fakhri B; Menke J; Ruiz-Cordero R; Gill RM; Ohgami RS
    Ann Diagn Pathol; 2020 Jun; 46():151534. PubMed ID: 32473554
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Morphoimmunohistological differential diagnosis between Hodgkin's lymphoma with lymphoid prevalence and large B-cell lymphoma].
    Kovrigina AM; Probatova NA
    Arkh Patol; 2005; 67(4):10-6. PubMed ID: 16209291
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gray-zone lymphoma. Examples of rare clinical manifestation.
    Misyurina AE; Kravchenko SK; Mangasarova YK; Magomedova AU; Kovrigina AM; Shimanovskaya LT; Fastova EA; Misyurin VA; Model SV; Chebotarev DI; Kostina IE; Savchenko VG
    Ter Arkh; 2019 May; 91(4):107-113. PubMed ID: 31094484
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumor microenvironment contribution to checkpoint blockade therapy: lessons learned from Hodgkin lymphoma.
    Carbone A; Gloghini A; Carlo-Stella C
    Blood; 2023 May; 141(18):2187-2193. PubMed ID: 36898085
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Update on nodular lymphocyte predominant Hodgkin's lymphoma and related lesions].
    Hartmann S; Hansmann ML
    Pathologe; 2017 Feb; 38(1):3-10. PubMed ID: 27999937
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bone Marrow Involvement in Patients With Nodular Lymphocyte Predominant Hodgkin Lymphoma.
    Agbay RLMC; Loghavi S; Zuo Z; Fayad L; Dabaja B; Medeiros LJ; Khoury JD
    Am J Surg Pathol; 2018 Apr; 42(4):492-499. PubMed ID: 29309302
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.
    Savage KJ; Monti S; Kutok JL; Cattoretti G; Neuberg D; De Leval L; Kurtin P; Dal Cin P; Ladd C; Feuerhake F; Aguiar RC; Li S; Salles G; Berger F; Jing W; Pinkus GS; Habermann T; Dalla-Favera R; Harris NL; Aster JC; Golub TR; Shipp MA
    Blood; 2003 Dec; 102(12):3871-9. PubMed ID: 12933571
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunoarchitectural patterns in nodular lymphocyte predominant Hodgkin lymphoma: pathologic and clinical implications.
    Gloghini A; Bosco A; Ponzoni M; Spina M; Carbone A
    Expert Rev Hematol; 2015 Apr; 8(2):217-23. PubMed ID: 25487651
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nodular lymphocyte-predominant hodgkin lymphoma or T-cell/histiocyte rich large B-cell lymphoma: the problem in "grey zone" lymphomas.
    Zhao FX
    Int J Clin Exp Pathol; 2008 Jan; 1(3):300-5. PubMed ID: 18784812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.